| Literature DB >> 25566442 |
Hee Geun Park1, Young Ran Lee1, Jong Kui Jun1, Wang Lok Lee1.
Abstract
PURPOSE: This study investigated the effect of exercise training and resveratrol supplementation with low fat diet on proinflammatory profiles by Lipopolysaccharide (LPS)-stimulation in peritoneal macrophage of high fat diet mice.Entities:
Keywords: High-fat diet; inflammation; macrophage; moderate exercise; resveratrol
Year: 2014 PMID: 25566442 PMCID: PMC4241938 DOI: 10.5717/jenb.2014.18.1.79
Source DB: PubMed Journal: J Exerc Nutrition Biochem ISSN: 2233-6834
| Product (#) | High fat Diet(D12451) | Low fat diet(D12450) | ||
|---|---|---|---|---|
| g% | kcal% | g% | kcal% | |
| Protein | 24 | 20 | 19.2 | 20 |
| Carbohydrate | 41 | 35 | 67.3 | 70 |
| Fat | 24 | 45 | 4.3 | 10 |
| Total | 100 | 100 | ||
| kcal/gm | 4.73 | 3.85 | ||
Comparison of body weight and plasma lipid profiles in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| Body weight (g) | 41.97±2.36 | 41.87±2.67 | 38.62±2.68[ | 4.864 | .017 |
| TG (mg/dl) | 83.01±24.39 | 68.50±11.66 | 79.62±10.38 | 2.223 | .143 |
| TC (mg/dl) | 195.14±13.18 | 196.00±25.63 | 157.50±29.18[ | 5.535 | .015 |
| LDL-C (mg/dl) | 125.88±58.97 | 137.18±26.14 | 106.40±4.44 | .805 | .465 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training. TG, triglyceride; TC, Total cholesterol; LDL-C, Low density lipoprotein cholesterol.
P < .05 versus HLC.
P < .05 versus HLR.
Comparison of TNF-α production in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| LPS non Stimulated (pg/ml) | 58.36±8.30 | 53.89±11.47 | 40.77±6.97[ | 5.026 | .026 |
| LPS-stimulated (0.5 μg/ml) (pg/ml) | 228.97±37.19 | 210.18±45.18 | 156.52±21.32[ | 5.464 | .021 |
| LPS-stimulated (1.0 μg/ml) (pg/ml) | 372.19±106.98 | 288.31±99.92 | 198.87±48.22[ | 4.743 | .030 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training.
P < .05 versus HLC.
Comparison of IL-6 production in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| LPS non Stimulated (pg/ml) | 52.05 ±20.60 | 61.78±18.04 | 40.78±10.12 | 1.943 | .186 |
| LPS-stimulated (0.5 μg/ml) (pg/ml) | 73.80±33.27 | 89.84 ±28.16 | 56.56±14.84 | 1.959 | .184 |
| LPS-stimulated (1.0 μg/ml) (pg/ml) | 528.69±131.51 | 316.05± 100.26[ | 255.29±69.40[ | 9.610 | .003 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training.
P < .05 versus HLC.
Comparison of IL-12p70 production in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| LPS non Stimulated (pg/ml) | 15.45±3.62 | 14.42±2.45 | 12.48±1.27 | 1.637 | .235 |
| LPS-stimulated (0.5 μg/ml) (pg/ml) | 13.84±2.41 | 13.07±2.05 | 12.21±1.37 | .838 | .456 |
| LPS-stimulated (1.0 μg/ml) (pg/ml) | 20.04±15.10 | 15.10±2.12 | 11.00±2.88[ | 9.551 | .003 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training.
P < .05 versus HLC.
Comparison of IFN- γ production in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| LPS non Stimulated (pg/ml) | 2.70±0.41 | 2.69±0.99 | 2.10±0.28 | 1.401 | .284 |
| LPS-stimulated (0.5 μg/ml) (pg/ml) | 4.59±0.33 | 4.11±1.54 | 3.20±0.72 | 2.452 | .128 |
| LPS-stimulated (1.0 μg/ml) (pg/ml) | 12.93±0.55 | 13.16±0.52 | 11.18±1.38[ | 6.989 | .010 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training.
P < .05 versus HLC.
P < .05 versus HLR.
Comparison of IL-10 production in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| LPS non Stimulated (pg/ml) | 86.56±14.11 | 84.52±10.41 | 84.52±9.86 | .050 | .952 |
| LPS-stimulated (0.5 μg/ml) (pg/ml) | 102.20±14.82 | 90.43±10.32 | 84.78±12.13 | 2.500 | .124 |
| LPS-stimulated (1.0 μg/ml) (pg/ml) | 186.81±35.14 | 174.61±53.00 | 144.28±34.74 | 1.370 | .291 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training.
Comparison of MCP-1 production in each group
| Group | HLC | HLR | HLE | F | p |
|---|---|---|---|---|---|
| LPS non Stimulated (pg/ml) | 13.39±3.28 | 11.80±3.11 | 7.57±0.90[ | 6.361 | .013 |
| LPS-stimulated (0.5 μg/ml) (pg/ml) | 22.85±4.90 | 18.07±5.95 | 11.12±2.07[ | 8.182 | .006 |
| LPS-stimulated (1.0 μg/ml) (pg/ml) | 35.03±9.60 | 32.41±9.11 | 15.44±5.40[ | 8.292 | .005 |
Values are presented as mean ± SD. n = 10. HLC, high fat diet-low fat diet control; HLR, high fat diet-low fat diet with resveratrol supplementation; HLE, high fat diet-low fat diet with exercise training.
P < .05 versus HLC.
P < .05 versus HLR.